Skip to main content
Tata Chemicals Ltd logo

Tata Chemicals Ltd — Investor Relations & Filings

Ticker · TATACHEM ISIN · INE092A01019 LEI · 335800H6MURUA6FBOW17 BSE.NS Manufacturing
Open in API
Filings indexed 2,734 across all filing types
Latest filing 2026-04-22 Regulatory Filings
Country IN India
Listing BSE.NS TATACHEM

About Tata Chemicals Ltd

https://www.tatachemicals.com/

Tata Chemicals Ltd provides chemistry-led solutions through its Basic Chemistry and Specialty Products segments. It is a leading global producer of soda ash and sodium bicarbonate, serving sectors such as glass, detergents, pharmaceuticals, and food processing. The specialty portfolio includes agro sciences, nutritional sciences, and material sciences, with a focus on prebiotics, highly dispersible silica, and crop protection through its subsidiary, Rallis India. The company operates manufacturing facilities across four continents and invests in energy sciences, specifically lithium-ion battery materials. Its operations are characterized by innovation-driven R&D and sustainable manufacturing practices. By integrating science with sustainability, the company delivers essential ingredients and specialized solutions to a global customer base across industrial and agricultural markets.

Recent filings

Filing Released Lang Actions
Board Meeting — Board Meeting Intimation
Regulatory Filings
2026-04-22 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is an intimation letter to stock exchanges about an upcoming Analysts’/Investors Call to discuss the audited consolidated and standalone financial results for the quarter and year ended March 31, 2026. It includes details about the conference call scheduled for May 4, 2026, with management participation and Q&A session. The document does not contain the actual financial results or detailed financial data but is an announcement of the call event. Therefore, it is classified as a Call Transcript (CT) announcement, but since it is only the intimation of the call and not the transcript itself, it fits best under Regulatory Filings (RNS) as a general regulatory announcement about the call. The document length is short (2758 characters), and it is primarily an announcement, not the transcript or report itself.
2026-04-22 English
Intimation of Analysts'/Investors Call under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Call Transcript Classification · 90% confidence The document is an intimation letter to stock exchanges about an upcoming Analysts’/Investors Call scheduled for May 4, 2026, to discuss the audited consolidated and standalone financial results for the quarter and year ended March 31, 2026. It includes details about the call timing, dial-in numbers, and participants. The document does not contain the actual financial results or a transcript of the call, but rather announces the event where such information will be discussed. Therefore, it is best classified as a Call Transcript (CT) announcement or invitation. However, since it is only an announcement of the call and not the transcript itself, the closest fitting category is Call Transcript (CT) as it relates directly to the earnings call event. Confidence is high given the clear mention of the call and its purpose.
2026-04-22 English
Board Meeting — Financial Results/Dividend
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges notifying them of an upcoming Board Meeting scheduled for May 4, 2026. The purpose of the meeting is to consider and approve audited financial results for the quarter and fiscal year ended March 31, 2026, and to recommend dividends for shareholder approval at the Annual General Meeting. The letter references compliance with SEBI regulations and insider trading rules. The document does not contain the financial results themselves, nor detailed financial data, but is an announcement of the meeting where such results will be approved. The document length is short (1761 characters), and it serves as an intimation or notice rather than a report. Therefore, it is best classified as a Regulatory Filing (RNS) because it is a regulatory announcement about a board meeting and upcoming financial results, not the financial report itself or a management report.
2026-04-22 English
Tata Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/05/2026 ,inter alia, to consider and approve i. Audited Consolidated and ....
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges notifying them of an upcoming Board Meeting scheduled for May 4, 2026. The purpose of the meeting includes considering and approving audited financial results for the quarter and financial year ended March 31, 2026, and recommending dividends for approval at the Annual General Meeting. The document references compliance with SEBI regulations and insider trading rules. The content is an announcement of a future event (Board Meeting) and does not contain actual financial results or detailed reports. The document length is short (1761 characters), and it serves as an intimation rather than the report itself. Therefore, it is best classified as a Regulatory Filing (RNS) since it is a general regulatory announcement and does not fit other specific categories like Annual Report or Earnings Release.
2026-04-22 English
General Updates
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges (NSE and BSE) regarding the voluntary strike-off and dissolution of two wholly owned subsidiaries of the company. It references compliance with SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, specifically Regulation 30 and Schedule III, which pertain to disclosure of material events or information. The document provides details about the subsidiaries' dissolution and clarifies that there is no financial transaction or change in ultimate ownership. The content is an announcement of a corporate structural change, not a financial report, earnings release, or management discussion. It is a regulatory announcement informing the exchanges and shareholders about the change in subsidiary status. Given the nature of the content and the regulatory references, this fits best under Regulatory Filings (RNS), which is the category for general regulatory announcements and compliance documents that do not fit other specific categories. The document length is under 5,000 characters and is a direct announcement, not a report or presentation.
2026-04-14 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.